Zobrazeno 1 - 10
of 26
pro vyhledávání: '"A Lopez De Torre Querejazu"'
Autor:
MJ Cumbraos Sanchez, C Blanco García, A Larrabeiti-Etxebarria, MM Mediavilla Garcia, A Lopez De Torre Querejazu, O Urbina Bengoa, MD Martinez García
Publikováno v:
Late breaking abstracts.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Domingo-Echaburu, S., Irazola, M., Prieto, A., Rocano, B., Lopez de Torre-Querejazu, A., Quintana, A., Orive, G., Lertxundi, U.
Publikováno v:
In Science of the Total Environment 10 May 2022 820
Autor:
de Juan Arroyo, A., Urrutia Losada, A., López de Torre Querejazu, A., Santos Ibáñez, A., Ibarra García, E., Palacios Zabalza, I.
Publikováno v:
In Farmacia Hospitalaria July-August 2012 36(4):220-228
Publikováno v:
Science of The Total Environment. 836:155729
Autor:
Ibarra Barrueta, O., Urrutia Losada, A., López de Torre Querejazu, A., Mayo Suárez, J., Martínez Gutiérrez, E., Martínez-Bengoechea, M.J.
Publikováno v:
In Farmacia Hospitalaria (English Edition) 2010 34(6):279-283
Publikováno v:
Science of The Total Environment. 817:152954
Healthcare workers can be exposed to dangerous drugs during their daily practice. The National Institute for Occupational Safety and Health (NIOSH) considers "hazardous drugs" as those that had shown one or more of the following characteristic in stu
Autor:
S. Domingo-Echaburu, M. Irazola, A. Prieto, B. Rocano, A. Lopez de Torre-Querejazu, A. Quintana, G. Orive, U. Lertxundi
Publikováno v:
The Science of the Total Environment
The city of Vitoria-Gasteiz was one of the probable first entrances of the SARS-CoV2 in Spain, one of the worst affected countries in the world during the first COVID 19 wave. Driven by the urgency of the situation, multiple drugs with antiviral acti
Publikováno v:
Farmacia Hospitalaria. 36:112-113
Autor:
M.J. Martínez-Bengoechea, A. Lopez-de-Torre Querejazu, J.L. Cabriada Nuño, I. Palacios Zabalza, A. de Juan Arroyo, E Ibarra Garcia, J. Peral Aguirregoitia, B. Corcostegui Santiago, M Bustos Martinez, O. Ibarra Barrueta
Publikováno v:
European Journal of Hospital Pharmacy. 19:233.2-233
Background The formation of perianal fistulas is a serious complication that affects up to 30% of patients with Cohn9s disease (CD). It has been suggested that intrafistula injection of infliximab could have some potential healing benefit becoming an